Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naloxone effect on hemodynamics and bleeding in general anesthesia
IRCT20101122005225N10Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Apr 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of naloxone, sponsored by Tehran University of Medical Sciences. Primary endpoints: Hemodynamic parameters and Bleeding rate. Started Apr 2022; status: completed.
02
Drugs
naloxone
Beyond the preview
Go deeper on IRCT20101122005225N10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20101122005225N10.